Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review

QR Code

Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review

Saved in:

Bibliographic Details
Main Authors:	Xiangyu Xu, Zheng Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	non-small cell lung cancer (NSCLC) brain metastasis programmed cell death ligand 1 tumor mutational burden (TMB) pathological complete response (PCR) circulating tumor DNA (ctDNA)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1660020/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 & TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review
by: Xiangyu Xu, et al.
Published: (2025-07-01)

Longitudinal Circulating Tumor DNA–Guided Resistance Analysis During Second-Line Osimertinib Treatment
by: J.W. Tijmen van der Wel, MD, et al.
Published: (2025-09-01)

Performance Comparison of Droplet Digital PCR and Next‐Generation Sequencing for Circulating Tumor DNA Detection in Non‐Metastatic Rectal Cancer
by: Säde Szeto, et al.
Published: (2025-05-01)

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients
by: Dong Lin, et al.
Published: (2025-07-01)

Clinical Utility of ctDNA Analysis in Lung Cancer—A Review
by: Kamil Makar, et al.
Published: (2025-06-01)

Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives
by: Yi Wang, et al.
Published: (2025-07-01)

Circulating Tumor DNA in Primary and Secondary Liver Cancers: A Comprehensive Review
by: Hanna Hong, et al.
Published: (2025-06-01)

Combining the DNA methylation markers of circulating tumor cells with immune infiltrating cells to assess recurrence and prognosis and to suggest a therapeutic strategy in stage III-IV colorectal cancer
by: Juan Zhou, et al.
Published: (2025-07-01)

The advances of DNA methylation in the liquid biopsy for the detection of lung cancer
by: Yuxuan Chen, et al.
Published: (2025-07-01)

Methylation of the tumor associated genes in head and neck squamous cell carcinoma
by: S. V. Kurevlev, et al.
Published: (2023-03-01)

Trabectedin – the DNA minor groove binder
by: G. A. Belitsky, et al.
Published: (2015-06-01)

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside Implementations
by: Xuehan Yan, et al.
Published: (2025-06-01)

Programmed death ligand 1 (PD-L1) expression in gastric cancer: literature review
by: T. N. Sotnikova, et al.
Published: (2023-07-01)

Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents
by: Anne C. Chiang, MD, PhD, et al.
Published: (2025-09-01)

The role of liquid biopsy in the diagnosis of glioblastoma progression
by: A. I. Ryabova, et al.
Published: (2022-06-01)

Effects of exercise on inflammation, circulating tumor cells, and circulating tumor DNA in colorectal cancer
by: Justin C. Brown, et al.
Published: (2025-12-01)

Liquid biopsy in TNBC: significance in diagnostics, prediction, and treatment monitoring
by: Jiayi Sheng, et al.
Published: (2025-08-01)

Liquid Biopsy for Colorectal Cancer: Advancing Detection and Clinical Application
by: Yan Li, et al.
Published: (2025-03-01)

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR
by: Stavroula Smilkou, et al.
Published: (2025-07-01)

Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC)
by: Khashayar Yazdanpanah Ardakani, et al.
Published: (2025-07-01)

Liquid Biopsy: Current Status and Future Perspective in Gastric Cancer and Helicobacter Infection
by: Eun A Kang, et al.
Published: (2018-09-01)

Association Between HPV Circulating Tumor DNA and Prognostic Inflammatory Indices in Oropharyngeal Squamous Cell Carcinoma: A Pilot Study
by: Ryan S. Ziltzer, et al.
Published: (2025-04-01)

Revealing the heterogeneity of treatment resistance in less‐defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy
by: Wei Hua, et al.
Published: (2025-01-01)

Unveiling ctDNA Response: Immune Checkpoint Blockade Therapy in a Patient with POLE Mutation-Associated Early-Onset Colon Cancer
by: Ramya Ramachandran, et al.
Published: (2025-06-01)

A consultation and work-up diagnosis protocol for a multicancer early detection test: a case series study
by: Luu Hong Dang Nguyen, et al.
Published: (2024-12-01)

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing
by: Xianyu Zhang, et al.
Published: (2025-06-01)

Changes in the concentration of freely circulating mutant DNA and wild-type DNA of the H3F3А (K27M) gene in the blood and cerebrospinal fluid of children with diffuse midline gliomas during a course of radiation therapy
by: O. S. Regentova, et al.
Published: (2024-09-01)

A 4-Methylbenzoylhydrazine Pt(II) Complex Inhibits the Proliferation of Breast Cancer Cells by Regulating the Cell Cycle and Inducing Apoptosis
by: Huiping Wang, et al.
Published: (2025-05-01)

THE ROLE OF INTRATUMORAL DENDRITIC CELLS IN THE PROGRESSION OF SQUAMOUS CELL CARCINOMAS
by: L. N. Bondar, et al.
Published: (2019-09-01)

Biomarkers for prediction and diagnostics of preeclampsia
by: O. V. Radkov, et al.
Published: (2018-04-01)

Synergizing Liquid Biopsy and Hybrid PET Imaging for Prognostic Assessment in Prostate Cancer: A Focus Review
by: Federica Stracuzzi, et al.
Published: (2025-07-01)

Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics
by: Lorenzo Foffano, et al.
Published: (2025-09-01)

The Power of Old Hats: Rediscovering Inosine-EpPCR to Create Starting Libraries for Whole-Cell-SELEX
by: Grigory Bolotnikov, et al.
Published: (2025-07-01)

GLAD-PCR assay of DNA methylation sites in regulatory regions of some tumor-suppressor genes in breast cancer
by: N. A. Smetannikova, et al.
Published: (2022-01-01)

Circulating cell-free DNA and tumor DNA dynamics in obstructive colon cancer undergoing neoadjuvant chemotherapy following stent placement
by: Kunning Zhang, et al.
Published: (2025-07-01)

Integration of Liquid Biopsy for Optimal Management of Non-small Cell Lung Cancer
by: Yuko Oya, et al.
Published: (2025-07-01)

Aberrations of DNA methylation in cancer
by: V. P. Maksimova, et al.
Published: (2022-12-01)

Detection of residual <i>E. coli</i> and CHO<i></i>host-cell<i></i>DNA in recombinant proteins by qPCR
by: N. D. Yolshin
Published: (2018-02-01)

Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer Patients by Multiple Datasets
by: Khyber Shinwari, et al.
Published: (2022-04-01)

IMMUNOLOGICAL REACTIVITY AND PERIPHERAL BLOOD DNA-CYTOMETRY IN CHILDHOOD ONCOLOGICAL DISEASES
by: Z. R. Khamatdinova, et al.
Published: (2014-07-01)